Anticholinergic, antimuscarinic bronchodilators
NJ Gross, MS Skorodin - American Review of Respiratory Disease, 1984 - atsjournals.org
The anticholinergic, antimuscarinic compounds are potent and hitherto neglected
bronchodilators. Although atropine itself has drawbacks, principally related to its rapid …
bronchodilators. Although atropine itself has drawbacks, principally related to its rapid …
Salbutamol in the 1980s: a reappraisal of its clinical efficacy
AH Price, SP Clissold - Drugs, 1989 - Springer
Salbutamol in the 1980s | Drugs Skip to main content SpringerLink Account Menu Find a
journal Publish with us Track your research Search Cart 1.Home 2.Drugs 3.Article Salbutamol …
journal Publish with us Track your research Search Cart 1.Home 2.Drugs 3.Article Salbutamol …
Inhaled formoterol dry powder versus ipratropium bromide in chronic obstructive pulmonary disease
R Dahl, LAPM Greefhorst, D Nowak… - American journal of …, 2001 - atsjournals.org
We compared the effectiveness of inhaled formoterol with that of ipratropium in the treatment
of chronic obstructive pulmonary disease (COPD). After a 2-wk run-in period, 780 patients …
of chronic obstructive pulmonary disease (COPD). After a 2-wk run-in period, 780 patients …
A comparison of the bronchodilating effects of a beta-2 adrenergic agent (albuterol) and an anticholinergic agent (ipratropium bromide), given by aerosol alone or in …
PA Easton, C Jadue, S Dhingra… - New England Journal …, 1986 - Mass Medical Soc
We evaluated the effect of anticholinergic and beta-adrenergic inhaled bronchodilators,
alone or in sequence, in 11 patients with chronic obstructive pulmonary disease. We …
alone or in sequence, in 11 patients with chronic obstructive pulmonary disease. We …
Comparison of the anticholinergic bronchodilator ipratropium bromide with metaproterenol in chronic obstructive pulmonary disease: a 90-day multi-center study
DP Tashkin, K Ashutosh, ER Bleecker, EJ Britt… - The American journal of …, 1986 - Elsevier
The short-and long-term efficacy and safety of an inhaled quaternary ammonium
anticholinergic agent, ipratropium bromide, and a beta agonist aerosol, metaproterenol …
anticholinergic agent, ipratropium bromide, and a beta agonist aerosol, metaproterenol …
Anticholinergic agents for chronic asthma in adults
MJ Westby, MK Benson… - Cochrane Database of …, 2004 - cochranelibrary.com
Background Anticholinergic agents such as ipratropium bromide are sometimes used in the
treatment of chronic asthma. They effect bronchodilation and have also been used in …
treatment of chronic asthma. They effect bronchodilation and have also been used in …
Comparison of nebulised salbutamol and ipratropium bromide with salbutamol alone in the treatment of chronic obstructive pulmonary disease.
P Moayyedi, J Congleton, RL Page, SB Pearson… - Thorax, 1995 - thorax.bmj.com
BACKGROUND--Patients admitted with acute exacerbation of chronic obstructive pulmonary
disease (COPD) are often prescribed ipratropium bromide in combination with a beta 2 …
disease (COPD) are often prescribed ipratropium bromide in combination with a beta 2 …
Nebulized ipratropium bromide in the treatment of acute asthma
DH Bryant - Chest, 1985 - journal.chestnet.org
MATERIALS AND METHODS A total of 28 patients (Table 1) admitted to hospital because of
acute asthma were included in this study, and their informed written consent was obtained …
acute asthma were included in this study, and their informed written consent was obtained …
Nebulized bronchodilators for outpatient management of stable chronic obstructive pulmonary disease
GL Colice - The American journal of medicine, 1996 - Elsevier
The bronchodilator efficacy, safety, and persistence of effect of the anticholinergic agent
ipratropium bromide and the β-adrenergic agonist albuterol, both given by nebulization …
ipratropium bromide and the β-adrenergic agonist albuterol, both given by nebulization …
Adverse reaction to ipratropium bromide.
CK Connolly - British Medical Journal (Clinical research ed.), 1982 - ncbi.nlm.nih.gov
934 BRITISH MEDICAL JOURNAL VOLUME 285 2 OCTOBER 1982 bronchiolectasis per se
would increase intrapulmonary shunts, though destruction of the pulmonary capillary bed …
would increase intrapulmonary shunts, though destruction of the pulmonary capillary bed …